TITLE

Recipient seropositivity for adenovirus type 11 (AdV11) is a highly predictive factor for the development of AdV11-induced hemorrhagic cystitis after allogeneic hematopoietic SCT

AUTHOR(S)
Nakazawa, Y; Saito, S; Yanagisawa, R; Suzuki, T; Ito, T; Ishida, F; Muramatsu, H; Matsumoto, K; Kato, K; Ishida, H; Umeda, K; Adachi, S; Nakahata, T; Koike, K
PUB. DATE
May 2013
SOURCE
Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p737
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A letter to the editor is presented which discusses the seropositivity of recipients of allogeneic hematopoietic stem cells transplantation (HSCT) for adenovirus type 11 (AdV11).
ACCESSION #
87496994

 

Related Articles

  • Risk factors identified for adenovirus infection in HSCT patients. Richards, Cassandra A. // Infectious Diseases in Children;Oct2012, Vol. 25 Issue 10, p11 

    The article presents information on research which examined the risk factors for adenovirus infection in children with hematopoietic stem cells transplant (HSCT).

  • Adenovirus Infections in Hematopoietic Stem Cell Transplant Recipients. Howard, Dianna S.; Phillips II, Gordon L.; Reece, Donna E.; Munn, Riat K.; Henslee-Downey, Jean; Pittard, Melissa; Barker, Matthew; Pomeroy, Claire // Clinical Infectious Diseases;12/1/1999, Vol. 29 Issue 6, p1494 

    Discusses an incidence of adenovirus infections among recipients of hematopoietic stem cell transplant (HSCT) from January to March 1997. Comparison between recipients of allogeneic and autologous stem cells; Correlation between the isolation of adenovirus from more than 1 site and risk for...

  • Risk factors identified for adenovirus infection in HSCT patients.  // Infectious Disease News;Oct2012, Vol. 25 Issue 10, p57 

    The article discusses research on adenovirus infection risk factors in pediatric hematopoietic stem cells transplant (HSCT) patients, conducted by Linda Feghoul and colleagues, presented at the 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held in California.

  • Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Ljungman, P; Ribaud, P; Eyrich, M; Matthes-Martin, S; Einsele, H; Bleakley, M; Machaczka, M; Bierings, M; Bosi, A; Gratecos, N; Cordonnier, C // Bone Marrow Transplantation;3/15/2003, Vol. 31 Issue 6, p481 

    Adenovirus is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation and there is no established therapy. Cidofovir has in vitro efficacy against adenovirus. We performed a retrospective analysis of 45 patients treated with cidofovir for adenovirus...

  • Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters. Toth, Karoly; Baoling Ying; Tollefson, Ann E.; Spencer, Jacqueline F.; Balakrishnan, Lata; Sagartz, John E.; Buller, Robert Mark L.; Wold, William S. M. // Viruses (1999-4915);2015, Vol. 7 Issue 3, p1409 

    Adenovirus infections of immunocompromised pediatric hematopoietic stem cell transplant patients can develop into serious and often deadly multi-organ disease. There are no drugs approved for adenovirus infections. Cidofovir (an analog of 2-deoxycytidine monophosphate) is used at times but it...

  • Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Yilmaz, M; Chemaly, R F; Han, X Y; Thall, P F; Fox, P S; Tarrand, J J; De Lima, M J; Hosing, C M; Popat, U R; Shpall, E; Champlin, R E; Qazilbash, M H // Bone Marrow Transplantation;Sep2013, Vol. 48 Issue 9, p1218 

    Disseminated adenoviral infection (AI) is associated with profound immunosuppression and poor outcome after allogeneic hematopoietic SCT (allo-HSCT). A better understanding of AI in allo-HSCT recipients can serve as a basis to develop more effective management strategies. We evaluated all adult...

  • Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Myers, G. D.; Bollard, C. M.; Wu, M.-F.; Weiss, H.; Rooney, C. M.; Heslop, H. E.; Leen, A. M. // Bone Marrow Transplantation;Jun2007, Vol. 39 Issue 11, p677 

    Adenovirus (adv) is a significant cause of morbidity and mortality in pediatric hematopoietic stem cell transplant recipients, and control of infection seems to require antigen-specific T cells. We evaluated the recovery of adv-specific cellular immunity in this patient population related to...

  • Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections. Gerdemann, Ulrike; Keirnan, Jacqueline M; Katari, Usha L; Yanagisawa, Ryu; Christin, Anne S; Huye, Leslie E; Perna, Serena K; Ennamuri, Sravya; Gottschalk, Stephen; Brenner, Malcolm K; Heslop, Helen E; Rooney, Cliona M; Leen, Ann M // Molecular Therapy;Aug2012, Vol. 20 Issue 8, p1622 

    Severe and fatal viral infections remain common after hematopoietic stem cell transplantation. Adoptive transfer of cytotoxic T lymphocytes (CTLs) specific for Epstein-Barr virus (EBV), cytomegalovirus (CMV), and adenoviral antigens can treat infections that are impervious to conventional...

  • Adenovirus Infections after Hematopoietic Stem Cell Transplantation: Still Unravelling the Story. Chakrabarti, Suparno // Clinical Infectious Diseases;10/15/2007, Vol. 45 Issue 8, p966 

    The article presents the author's comments on various studies related to adenovirus infections after hematopoietic stem cell transplantation. According to the author, a study by researcher V. Erard and colleagues highlights several interesting aspects of a retrospective analysis. The author says...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics